Cofactor’s cancer biomarker test outshines standard ICI predictive tests
Cofactor Genomics has showcased positive data highlighting that its clinical biomarker assay OncoPrism-HNSCC could guide doctors in choosing more effective…
All articles by Jenna Philpott
Jenna Philpott
Jenna Philpott is a healthcare and pharmaceutical reporter. Coming from a scientific background, Jenna has expertise in biochemistry, genetics and cancer science. Jenna previously wrote freelance articles focused on oncology and healthcare.
-
-
Vidac secures funding to advance skin cancer trials of novel ointment
Vidac Pharma has secured €600,000 ($645,651) in additional funding to support the clinical development of its two lead cancer candidates. …
-
GSK CEO addresses declining trust in vaccines following Trump re-election
Following Donald Trump’s re-election as the 47th President of the United States, the global healthcare community is beginning to examine…
-
J&J’s Shockwave deal pays off as IVL catheter meets primary endpoint in trial
Johnson & Johnson’s (J&J) Shockwave Medical unit has reported that its Javelin peripheral intravascular lithotripsy (IVL) catheter system successfully met…
-
Disc teases potential NDA for rare skin disorder drug
Disc Medicine has announced a US Food and Drug Administration (FDA) agreement on the regulatory path for its investigational drug…
-
Teva’s long-lasting schizophrenia injectable shines in Phase III
Teva Pharmaceuticals’ TEV-‘749 (olanzapine) has shown statistical improvement in schizophrenia symptoms in a Phase III trial. The Phase III SOLARIS…
-
Ethics and regulation come into focus in the age of AI-powered clinical trials
As the role of technology and digital tools in clinical trials expands, industry leaders are grappling with how to balance…
-
Sunbird Bio’s Parkinson’s diagnostic blood test showcases 86% accuracy
Sunbird Bio has unveiled new data demonstrating that its diagnostic technology classified Parkinson’s disease-positive blood samples with 86% accuracy through…
-
Sinaptica’s neuromodulation device aces Phase II Alzheimer’s trial
A Phase II clinical trial evaluating Sinaptica Therapeutics’ neuromodulation device in Alzheimer’s disease has hit its primary and key secondary…
-
Global “research waste” addressed by WHO’s clinical trial guidance
The World Health Organization’s (WHO) new framework aimed at strengthening clinical trial systems addresses a global issue of “major research…